150 related articles for article (PubMed ID: 15504247)
1. Activation of c-Met (hepatocyte growth factor receptor) in human gastric cancer tissue.
Inoue T; Kataoka H; Goto K; Nagaike K; Igami K; Naka D; Kitamura N; Miyazawa K
Cancer Sci; 2004 Oct; 95(10):803-8. PubMed ID: 15504247
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.
Huang TJ; Wang JY; Lin SR; Lian ST; Hsieh JS
Acta Oncol; 2001; 40(5):638-43. PubMed ID: 11669338
[TBL] [Abstract][Full Text] [Related]
3. [The overexpression of c-met oncogene correlation with gastric mucosal lesion].
Wang J; Lü Y; Li J
Zhonghua Yi Xue Za Zhi; 1996 May; 76(5):359-62. PubMed ID: 9206200
[TBL] [Abstract][Full Text] [Related]
4. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.
Heideman DA; Snijders PJ; Bloemena E; Meijer CJ; Offerhaus GJ; Meuwissen SG; Gerritsen WR; Craanen ME
J Pathol; 2001 Aug; 194(4):428-35. PubMed ID: 11523050
[TBL] [Abstract][Full Text] [Related]
5. Increased HGF Expression Induces Resistance to c-MET Tyrosine Kinase Inhibitors in Gastric Cancer.
Ahn SY; Kim J; Kim MA; Choi J; Kim WH
Anticancer Res; 2017 Mar; 37(3):1127-1138. PubMed ID: 28314274
[TBL] [Abstract][Full Text] [Related]
6. c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis.
Nakamura Y; Niki T; Goto A; Morikawa T; Miyazawa K; Nakajima J; Fukayama M
Cancer Sci; 2007 Jul; 98(7):1006-13. PubMed ID: 17459054
[TBL] [Abstract][Full Text] [Related]
7. [Increased expression of the c-Met receptor mRNA in gastric cancer].
Amemiya H; Peña A; Chiurillo M; Moscoso J; Useche A; Baffi R
Invest Clin; 2013 Sep; 54(3):284-98. PubMed ID: 24354242
[TBL] [Abstract][Full Text] [Related]
8. [Role of the expression of c-Met receptor in the progression of gastric cancer].
Amemiya H; Menolascino F; Peña A
Invest Clin; 2010 Sep; 51(3):369-80. PubMed ID: 21305773
[TBL] [Abstract][Full Text] [Related]
9. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
10. Presence of autocrine hepatocyte growth factor-Met signaling and its role in proliferation and migration of SNU-484 gastric cancer cell line.
Park M; Park H; Kim WH; Cho H; Lee JH
Exp Mol Med; 2005 Jun; 37(3):213-9. PubMed ID: 16000876
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma.
Wu CW; Li AF; Chi CW; Chung WW; Liu TY; Lui WY; P'eng FK
Oncol Rep; 1998; 5(4):817-22. PubMed ID: 9625824
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and clinical pathology of MACC-1 and c-MET expression in gastric carcinoma.
Ma J; Ma J; Meng Q; Zhao ZS; Xu WJ
Pathol Oncol Res; 2013 Oct; 19(4):821-32. PubMed ID: 23812675
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of c-Met is correlated with c-Met overexpression and dependent on cell-matrix adhesion in lung adenocarcinoma cell lines.
Nakamura Y; Matsubara D; Goto A; Ota S; Sachiko O; Ishikawa S; Aburatani H; Miyazawa K; Fukayama M; Niki T
Cancer Sci; 2008 Jan; 99(1):14-22. PubMed ID: 17953713
[TBL] [Abstract][Full Text] [Related]
15. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
Murakami N; Koufuji K; Shirouzu K
Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
[TBL] [Abstract][Full Text] [Related]
17. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
18. [Expression of hepatocyte growth factor and its receptor in gastric cancer].
Chen JZ; Zhao Y; Xu JF; Liu Q; Liu SH; Zhang HD
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1771-3. PubMed ID: 18024311
[TBL] [Abstract][Full Text] [Related]
19. MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.
Sakamoto N; Tsujimoto H; Takahata R; Cao B; Zhao P; Ito N; Shimazaki H; Ichikura T; Hase K; Vande Woude GF; Shinomiya N
Cancer Sci; 2017 Mar; 108(3):322-330. PubMed ID: 28012218
[TBL] [Abstract][Full Text] [Related]
20. MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas.
Ha SY; Lee J; Kang SY; Do IG; Ahn S; Park JO; Kang WK; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Ignatius Ou SH; Kim KM
Mod Pathol; 2013 Dec; 26(12):1632-41. PubMed ID: 23807774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
